Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
UPMC Enterprises supporting UPMC response to COVID-19
We are temporarily redirecting our content resources to supporting UPMC’s response to COVID-19.
Read More →
UPMC Enterprises Celebrates International Women’s Day
March 8th is International Women’s Day and many organizations around the world came together to …
Read More →